$ Value
$0
Shares
1,732
Price
$0
Filed
May 20
Insider
Name
Maunsell Farris Maryanne
Title
VP, Chief Accounting Officer
CIK
0001950052
Roles
Transaction Details
Transaction Date
2025-05-16
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,732
Footnotes
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. | This number includes unvested RSUs previously reported. | Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.